Move-in is set for early May. Renovations for the firm's new headquarters are part of a $44 million update of the Bulkley ...
Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results